Our results demonstrate that hepcidin prohibits liver fibrosis by suppressing TGFβ1–Smad3 pathway in HSCs, which may depend on PI3K/Akt signalling elicited by FPN deficiency. The gene discussed is HAMP; the disease is Hepatic fibrosis.